Alyeska Investment Group
IMA

Alyeska Investment Group’s ImageneBio Inc IMA Stock Holding History

Alyeska Investment Group’s Portfolio IMA Stock Details IMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-8,333
Closed -$1.4M – 729
2021
Q2 		$1.4M Hold
8,333
– – 0.02% 560
2021
Q1 		$2.83M Buy
+8,333
New +$2.85M 0.04% 416

Other funds holding IMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Alyeska Investment Group's IMA Position: Q3 2021 in Review

Alyeska Investment Group sold out of ImageneBio Inc (IMA) in Q3 2021, closing a stake of 8,333 shares — an estimated $1.4M sold.

Alyeska Investment Group first reported a position in IMA in Q1 2021 and held it in 2 quarters. The position peaked at $2.83M in Q1 2021. 39 funds tracked by Wall St. Rank hold IMA as of Q3 2021.

  • Alyeska Investment Group reported no remaining ImageneBio Inc position as of Q3 2021 after selling out during the quarter.
  • Alyeska Investment Group sold 8,333 ImageneBio Inc shares in Q3 2021, an estimated $1.4M.
  • Alyeska Investment Group first reported a position in ImageneBio Inc in Q1 2021 and held it in 2 quarters.
  • Alyeska Investment Group's ImageneBio Inc position peaked at $2.83M in Q1 2021.
  • 39 funds tracked by Wall St. Rank held ImageneBio Inc as of Q3 2021.

Based on Alyeska Investment Group's 13F filing for Q3 2021, filed 15 Nov 2021.